Daniele Focosi

InstitutionPisa University Hospital
AddressPisa
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 34 Covid-19 publications, with a maximum of 5 publications in April 2021
    All Publications
    Bar chart showing 146 publications over 16 distinct years, with a maximum of 25 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Novazzi F, Genoni A, Spezia PG, Focosi D, Zago C, Colombo A, Cassani G, Pasciuta R, Tamborini A, Rossi A, Prestia M, Capuano R, Gasperina DD, Dentali F, Severgnini P, Ageno W, Gambarini C, Stefanelli P, Baj A, Maggi F. Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy. Emerg Microbes Infect. 2021 Dec; 10(1):710-712. PMID: 33739917.
      Citations: 4     Fields:    Translation:Humans
    2. Baj A, Novazzi F, Genoni A, Ferrante FD, Taborelli S, Pini B, Partenope M, Valli M, Gasperina DD, Capuano R, Prestia M, Spezia PG, Azzi L, Focosi D, Maggi F. Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution. Emerg Microbes Infect. 2021 Dec; 10(1):1254-1256. PMID: 34110974.
      Citations:    Fields:    Translation:HumansPHPublic Health
    3. Focosi D, Macera L, Spezia PG, Ceccarelli F, Lanza M, Maggi F. Molecular validation of pathogen-reduction technologies using rolling-circle amplification coupled with real-time PCR for torquetenovirus DNA quantification. Transfus Med. 2021 Oct; 31(5):371-376. PMID: 34390068.
      Citations:    Fields:    Translation:HumansCells
    4. Focosi D, Franchini M, Pirofski LA, Burnouf T, Fairweather D, Joyner MJ, Casadevall A. COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors. Viruses. 2021 08 11; 13(8). PMID: 34452459.
      Citations:    Fields:    Translation:HumansCells
    5. Focosi D, Navarro D, Maggi F, Roilides E, Antonelli G. COVID-19 infodemics: the role of mainstream and social media. Clin Microbiol Infect. 2021 Nov; 27(11):1568-1569. PMID: 34375756.
      Citations:    Fields:    Translation:Humans
    6. Baj A, Novazzi F, Ferrante FD, Genoni A, Cassani G, Prestia M, Colombo A, Capuano R, Zago C, Pasciuta R, Tamborini A, Rossi A, Tettamanzi E, Catanoso G, Focosi D, Maffioli L, Maggi F. Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy. J Med Virol. 2021 Dec; 93(12):6460-6461. PMID: 34314049.
      Citations: 4     Fields:    Translation:Humans
    7. Castelli M, Baj A, Criscuolo E, Ferrarese R, Diotti RA, Sampaolo M, Novazzi F, Dalla Gasperina D, Focosi D, Ferrari D, Locatelli M, Clementi M, Clementi N, Maggi F, Mancini N. Characterization of a Lineage C.36 SARS-CoV-2 Isolate with Reduced Susceptibility to Neutralization Circulating in Lombardy, Italy. Viruses. 2021 07 31; 13(8). PMID: 34452380.
      Citations: 2     Fields:    Translation:Humans
    8. Tuccori M, Convertino I, Ferraro S, Valdiserra G, Cappello E, Fini E, Focosi D. An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future. Expert Opin Drug Discov. 2021 12; 16(12):1403-1414. PMID: 34304682.
      Citations:    Fields:    Translation:HumansPHPublic Health
    9. Focosi D, Novazzi F, Genoni A, Dentali F, Gasperina DD, Baj A, Maggi F. Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19. Emerg Infect Dis. 2021 Oct; 27(10):2728-2731. PMID: 34314668.
      Citations: 5     Fields:    Translation:Humans
    10. Focosi D, Tuccori M, Baj A, Maggi F. SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies. Viruses. 2021 06 23; 13(7). PMID: 34201767.
      Citations: 6     Fields:    Translation:Humans
    11. Focosi D, Carla IM, Lanza M. ABO Blood Group Correlations with Covid-19: Cohort Choice Makes A Difference. Clin Infect Dis. 2021 06 01; 72(11):e919. PMID: 32997752.
      Citations: 2     Fields:    Translation:Humans
    12. Focosi D, Franchini M. Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations. Expert Rev Vaccines. 2021 May 27; 1-8. PMID: 34015243.
      Citations: 2     Fields:    
    13. Novazzi F, Baj A, Genoni A, Spezia PG, Colombo A, Cassani G, Zago C, Pasciuta R, Della Gasperina D, Ageno W, Severgnini P, Dentali F, Focosi D, Maggi F. SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients. J Med Virol. 2021 Sep; 93(9):5648-5649. PMID: 33969504.
      Citations: 3     Fields:    Translation:Humans
    14. Focosi D, Baj A, Maggi F. Is a single COVID-19 vaccine dose enough in convalescents ? Hum Vaccin Immunother. 2021 Sep 02; 17(9):2959-2961. PMID: 33950788.
      Citations: 5     Fields:    Translation:Humans
    15. Focosi D, Franchini M. Clinical predictors of SARS-CoV-2 neutralizing antibody titers in COVID-19 convalescents: Implications for convalescent plasma donor recruitment. Eur J Haematol. 2021 Jul; 107(1):24-28. PMID: 33780551.
      Citations: 6     Fields:    Translation:Humans
    16. Focosi D, Maggi F, Franchini M, Aguzzi A, Lanza M, Mazzoni A, Menichetti F. Patient-blood management for COVID19 convalescent plasma therapy: relevance of affinity and donor-recipient differences in concentration of neutralizing antibodies. Clin Microbiol Infect. 2021 Jul; 27(7):987-992. PMID: 33878505.
      Citations: 1     Fields:    Translation:Humans
    17. Maggi F, Rosellini A, Spezia PG, Focosi D, Macera L, Lai M, Pistello M, de Iure A, Tomino C, Bonassi S, Russo P. Nicotine upregulates ACE2 expression and increases competence for SARS-CoV-2 in human pneumocytes. ERJ Open Res. 2021 Apr; 7(2). PMID: 33850935.
      Citations: 1     
    18. Focosi D, Genoni A, Lucenteforte E, Tillati S, Tamborini A, Spezia PG, Azzi L, Baj A, Maggi F. Previous Humoral Immunity to the Endemic Seasonal Alphacoronaviruses NL63 and 229E Is Associated with Worse Clinical Outcome in COVID-19 and Suggests Original Antigenic Sin. Life (Basel). 2021 Apr 01; 11(4). PMID: 33915711.
      Citations: 7     
    19. Focosi D, Franchini M. COVID-19 convalescent plasma therapy: hit fast, hit hard! Vox Sang. 2021 10; 116(9):935-942. PMID: 33794556.
      Citations: 6     Fields:    Translation:Humans
    20. Azzi L, Focosi D, Dentali F, Baj A, Maggi F. Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients. Vaccine. 2021 04 28; 39(18):2489-2490. PMID: 33824042.
      Citations: 2     Fields:    
    21. Focosi D, Maggi F. Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines. Rev Med Virol. 2021 11; 31(6):e2231. PMID: 33724631.
      Citations: 17     Fields:    Translation:HumansCells
    22. Focosi D, Franchini M. Impact of pathogen-reduction technologies on COVID-19 convalescent plasma potency. Transfus Clin Biol. 2021 May; 28(2):132-134. PMID: 33675992.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    23. Focosi D, Tuccori M, Franchini M. The Road towards Polyclonal Anti-SARS-CoV-2 Immunoglobulins (Hyperimmune Serum) for Passive Immunization in COVID-19. Life (Basel). 2021 Feb 15; 11(2). PMID: 33671893.
      Citations: 6     
    24. Maggi F, Novazzi F, Genoni A, Baj A, Spezia PG, Focosi D, Zago C, Colombo A, Cassani G, Pasciuta R, Tamborini A, Rossi A, Prestia M, Capuano R, Azzi L, Donadini A, Catanoso G, Grossi PA, Maffioli L, Bonelli G. Imported SARS-CoV-2 Variant P.1 in Traveler Returning from Brazil to Italy. Emerg Infect Dis. 2021 04; 27(4):1249-1251. PMID: 33567246.
      Citations: 21     Fields:    Translation:Humans
    25. Focosi D, Franchini M. COVID-19 neutralizing antibody-based therapies in humoral immune deficiencies: A narrative review. Transfus Apher Sci. 2021 Jun; 60(3):103071. PMID: 33518427.
      Citations: 5     Fields:    Translation:Humans
    26. Ferraro S, Tuccori M, Convertino I, Valdiserra G, Cappello E, Maggi F, Blandizzi C, Focosi D. Olfactory and gustatory impairments in COVID-19 patients: Role in early diagnosis and interferences by concomitant drugs. Br J Clin Pharmacol. 2021 05; 87(5):2186-2188. PMID: 33185930.
      Citations: 1     Fields:    Translation:Humans
    27. Focosi D, Farrugia A. The art of the possible in approaching efficacy trials for COVID19 convalescent plasma. Int J Infect Dis. 2021 Jan; 102:244-246. PMID: 33130197.
      Citations: 3     Fields:    Translation:Humans
    28. Focosi D, Tuccori M, Antonelli G, Maggi F. What is the optimal usage of coronavirus disease 2019 convalescent plasma donations? Clin Microbiol Infect. 2021 Feb; 27(2):163-165. PMID: 33007479.
      Citations: 3     Fields:    Translation:Humans
    29. Focosi D, Maggi F, Mazzetti P, Pistello M. Viral infection neutralization tests: A focus on severe acute respiratory syndrome-coronavirus-2 with implications for convalescent plasma therapy. Rev Med Virol. 2021 03; 31(2):e2170. PMID: 33350017.
      Citations: 14     Fields:    Translation:HumansAnimalsPHPublic Health
    30. Focosi D, Anderson AO, Tang JW, Tuccori M. Convalescent Plasma Therapy for COVID-19: State of the Art. Clin Microbiol Rev. 2020 09 16; 33(4). PMID: 32792417.
      Citations: 25     Fields:    Translation:HumansPHPublic Health
    31. Tuccori M, Convertino I, Ferraro S, Cappello E, Valdiserra G, Focosi D, Blandizzi C. The Impact of the COVID-19 "Infodemic" on Drug-Utilization Behaviors: Implications for Pharmacovigilance. Drug Saf. 2020 08; 43(8):699-709. PMID: 32572842.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    32. Focosi D. Anti-A isohaemagglutinin titres and SARS-CoV-2 neutralization: implications for children and convalescent plasma selection. Br J Haematol. 2020 08; 190(3):e148-e150. PMID: 32516462.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    33. Convertino I, Tuccori M, Ferraro S, Valdiserra G, Cappello E, Focosi D, Blandizzi C. Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients. Crit Care. 2020 06 11; 24(1):331. PMID: 32527304.
      Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
    34. Tuccori M, Ferraro S, Convertino I, Cappello E, Valdiserra G, Blandizzi C, Maggi F, Focosi D. Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline. MAbs. 2020 Jan-Dec; 12(1):1854149. PMID: 33319649.
      Citations: 39     Fields:    Translation:Humans
    Focosi's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (142)
    Explore
    _
    Co-Authors (84)
    Explore
    _
    Similar People (60)
    Explore
    _